Literature DB >> 10487632

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level.

C A Coltman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10487632      PMCID： PMC2374364          DOI： 10.1038/sj.bjc.6690670

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  9 in total

1.  Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate.

Authors:  L A Eskew; R L Bare; D L McCullough
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

2.  Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate.

Authors:  T Niesel; J Breul; R Hartung
Journal:  Urology       Date:  1997-06       Impact factor: 2.649

Review 3.  The potential application of finasteride for chemoprevention of prostate cancer.

Authors:  G J Gormley; O Brawley; I Thompson
Journal:  Ann N Y Acad Sci       Date:  1995-09-30       Impact factor: 5.691

4.  The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

Authors:  J D McConnell; R Bruskewitz; P Walsh; G Andriole; M Lieber; H L Holtgrewe; P Albertsen; C G Roehrborn; J C Nickel; D Z Wang; A M Taylor; J Waldstreicher
Journal:  N Engl J Med       Date:  1998-02-26       Impact factor: 91.245

5.  A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats.

Authors:  S Tsukamoto; H Akaza; M Onozawa; T Shirai; Y Ideyama
Journal:  Cancer       Date:  1998-02-01       Impact factor: 6.860

6.  Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer.

Authors:  G Raviv; T Janssen; A R Zlotta; F Descamps; A Verhest; C C Schulman
Journal:  J Urol       Date:  1996-09       Impact factor: 7.450

7.  Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.

Authors:  I M Thompson; C A Coltman; J Crowley
Journal:  Prostate       Date:  1997-11-01       Impact factor: 4.104

8.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Authors:  R K Ross; L Bernstein; R A Lobo; H Shimizu; F Z Stanczyk; M C Pike; B E Henderson
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

9.  The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.

Authors:  R J Cote; E C Skinner; C E Salem; S J Mertes; F Z Stanczyk; B E Henderson; M C Pike; R K Ross
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.